Jtaylor, thanks for the link I had not watched that one for quite a while. Watched it on YouTube and then youtubr brought up a 2023 discussion on Musellafoundation with former COO of NVCR - 54 minute presentation and found it quite interesting. Still not a fan of TTF as looks hard to wear but he was talking of ongoing trials and one proposed is in collaboration with both NVCR and Merck to combine TTF with an immunotherapy- keytruda. I know ucla is using dcvax and keytruda bot not sponsored by nwbo (probably no $) though nwbo has talked of several trials they were to start but as of yet did not happen. He did talk of one patient (Daniel) on ttf now alive at 16 years - kind of similar to dcvax and Brad Silver. Let the bashing begin
Market Data 
Markets 
AI
